Related Experiment Video
Updated: Aug 12, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Metabolic alterations in cancer. Part I. Carbohydrate metabolism
Abstract:
Glucose intolerance seen in weight-losing patients may not result from qualitative or quantitative alterations in insulin secretion or binding. It may, however, be the result of increased gluconeogenic flux which occurs in these patients. This may be due to increased substrate availability resulting from lactate production as the unoxidized-end-product of tumour glycolysis (Warburg effect). In addition, increased levels of glucogenic amino acid may be associated with preferential amino acid sequestration by the tumour, causing decreased muscle proteogenesis and therefore atrophy. Enhanced glucose demand by tumour cells may also lead to an increased hepatic gluconeogenesis, as will the production of ectopic ACTH.
Related Concept Videos
Cancer
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

